|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/22/2024 |
$58.84 |
$59.60 |
$55.54 |
$55.78 |
275.10K | 04/23/2024 |
$56.15 |
$58.69 |
$54.93 |
$55.19 |
478.40K | 04/24/2024 |
$55.56 |
$57.60 |
$55.21 |
$56.24 |
311.70K | 04/25/2024 |
$55.05 |
$55.05 |
$53.24 |
$54.19 |
261.60K | 04/26/2024 |
$54.68 |
$58.45 |
$53.69 |
$57.86 |
292.00K |
|
Keros Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of treatments for hematological, pulmonary and cardiovascular disorders. Co.'s protein therapeutic product candidate, KER-050, is developed for the treatment of low blood cell counts, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, and in patients with myelofibrosis. Co.'s small molecule product candidate, KER-047, is developed for the treatment of functional iron deficiency. Co.'s third product candidate, KER-012, is developed for the treatment of pulmonary arterial hypertension, and for the treatment of cardiovascular disorders. | |
|
Keros Therapeutics (KROS) has the following price history information. Looking back at KROS historical stock prices for the last five trading days, on April 22, 2024, KROS opened at $58.84, traded as high as $59.60 and as low as $55.54, and closed at $55.78. Trading volume was a total of 275.10K shares. On April 23, 2024, KROS opened at $56.15, traded as high as $58.69 and as low as $54.93, and closed at $55.19. Trading volume was a total of 478.40K shares. On April 24, 2024, KROS opened at $55.56, traded as high as $57.60 and as low as $55.21, and closed at $56.24. Trading volume was a total of 311.70K shares. On April 25, 2024, KROS opened at $55.05, traded as high as $55.05 and as low as $53.24, and closed at $54.19. Trading volume was a total of 261.60K shares. On April 26, 2024, KROS opened at $54.68, traded as high as $58.45 and as low as $53.69, and closed at $57.86. Trading volume was a total of 292.00K shares.
KROS Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Keros Therapeutics shares, starting with a $10,000 purchase of KROS, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/09/2020 |
|
End date: |
04/26/2024 |
|
Start price/share: |
$21.57 |
|
End price/share: |
$57.86 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
168.24% |
|
Average Annual Total Return: |
27.59% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$26,821.61 |
|
Years: |
4.05 |
|
|
|
Date |
Close |
04/22/2024 | $55.78 | 04/23/2024 | $55.19 | 04/24/2024 | $56.24 | 04/25/2024 | $54.19 | 04/26/2024 | $57.86 |
|
|